CONTROLLED RELEASE DOSAGE FORM OF R-(Z)]-ALPHA-(METHOXYIMINO)-ALPHA-(1-AZABICYCLO 2.2.2]OCT-3-YL)ACETONITRILE MONOHYDROCHLORIDE

(19)

(11)

EP 0 929 301 A2

(12)

(43)	Date of publication:
	21.07.1999 Bulletin 1999/29

(21)	Application number: 97939064.0

(22)	Date of filing: 08.09.1997

(51)

International Patent Classification (IPC):

A61K 9/ 22^{( . )}
A61K 9/ 20^{( . )}
A61K 31/ 435^{( . )}
A61K 47/ 10^{( . )}
A61P 25/ 28^{( . )}

A61K 9/ 16^{( . )}
A61K 9/ 50^{( . )}
A61K 31/ 439^{( . )}
A61K 47/ 38^{( . )}

(86)	International application number:
	PCT/GB1997/002418

(87)	International publication number:
	WO 1998/010762 (19.03.1998 Gazette 1998/11)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

12.09.1996 GB 19960019074

(71)	Applicants:
	SMITHKLINE BEECHAM PLC Brentford, Middlesex TW8 9EP (GB) SMITHKLINE BEECHAM CORPORATION Philadelphia Pennsylvania 19103 (US)

(72)

Inventors:

MILOSOVICH, Susan, Marie, SmithKline Beecham Phar.
Collegeville, PA 19426-0989 (US)
MULDOON, William, SmithKline Beecham Pharmaceut.
Collegeville, PA 19426-0989 (US)
NAPPER, James Albert, SmithKline Beecham Pharma.
Harlow, Essex CM19 5AW (GB)
ROUSSEAU, Laurence, SmithKline Beecham Pharmaceut.
Harlow, Essex CM19 5AW (GB)
SAUER, Joseph, SmithKline Beecham Pharmaceuticals
Collegeville, PA 19426-0989 (US)

(74)	Representative: Valentine, Jill Barbara, et al
	SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court Brentford, Middlesex TW8 9EP Brentford, Middlesex TW8 9EP (GB)

(54)	CONTROLLED RELEASE DOSAGE FORM OF R-(Z)]-ALPHA-(METHOXYIMINO)-ALPHA-(1-AZABICYCLO 2.2.2]OCT-3-YL)ACETONITRILE MONOHYDROCHLORIDE